Coral Laboratories reported a rise in Q4 FY26 net profit to ₹5.22 crore from ₹2.83 crore year-on-year. However, FY26 revenue and net profit saw a decline. The company recommended a 20% final dividend.
Coral Laboratories reported a Q4 FY2026 net profit of ₹5.22 crore, up from ₹2.83 crore in Q4 FY2025. For the full fiscal year 2026, net profit stood at ₹16.38 crore, a decrease from ₹24.16 crore in FY2025. Revenue from operations for FY2026 was ₹85.90 crore, down from ₹115.01 crore in FY2025. Reader Takeaway: Quarterly profit recovery is a positive sign, but declining annual revenue signals a potential challenge ahead. ## What just happened Coral Laboratories announced its financial results for the fourth quarter and full year ended March 31, 2026. The company saw a notable increase in net profit for the fourth quarter compared to the same period last year. However, its overall annual revenue and net profit for FY2026 declined compared to FY2025. ## Why this matters Investors are presented with mixed signals. The improved quarterly performance suggests a potential turnaround, while the annual decline raises concerns about the company's overall growth trajectory and profitability. The recommended dividend offers a direct return to shareholders. ## The backstory Coral Laboratories operates solely in the 'Formulations' segment. The company's financial performance in the previous year, FY2025, showed higher revenue and profit compared to the latest fiscal year. Statutory auditors, S C Mehra & Associates LLP, issued an unmodified opinion on the standalone financial results. ## What changes now The company will proceed with recommending a final dividend of 20% (₹2.00 per share) for FY2026, subject to shareholder approval. Additionally, M/s. S K Doshi & Associates and M/s Aatish Dhatrak & Associates have been appointed as Internal Auditor and Cost Auditor, respectively, for FY2027. ## Risks to watch The primary risk for investors is the continued decline in annual revenue and profitability, indicating potential market challenges or operational inefficiencies that need to be addressed. The ability to reverse the annual trend will be critical. ## Peer comparison (No peer comparison data available in the filing.) ## Context metrics (time-bound) - **FY2026 Revenue:** ₹85.90 crore (vs ₹115.01 crore in FY2025) - **FY2026 Net Profit:** ₹16.38 crore (vs ₹24.16 crore in FY2025) - **Q4 FY2026 Net Profit:** ₹5.22 crore (vs ₹2.83 crore in Q4 FY2025) - **Recommended Dividend:** 20% (₹2.00 per share) ## What to track next Investors should closely monitor Coral Laboratories' future quarterly results to see if the positive trend in net profit continues and if the company can successfully reverse the decline in its annual revenue and overall profitability.
Get stock alerts instantly on WhatsApp
Quarterly results, bulk deals, concall updates and major announcements delivered in real time.
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.
